Digital
JPM2026: Broadening AI drug discovery to include the lab, wi...
Yann Gaston-Mathe, founder and CEO of Iktos, discusses AI drug discovery's shift to real-world operations that are able to incorporate wet lab data.
Oncology
On AI and equity in the cancer setting, with Mohit Manrao
Deep Dive editor Eloise McLennan speaks with Mohit Manrao, SVP, head of US oncology at AstraZeneca, and president of the AstraZeneca Foundation.
Digital
JPM2026: AI diagnostics and translational research, with And...
On the sidelines of JPM2026, pharmaphorum spoke with Andrew Beck, co-founder and CEO at PathAI, about AI diagnostics in pathology.
R&D
Shaping the future of immunodeficiency care, with Dr Jörg Sc...
Dr Jörg Schüttrumpf, Chief Scientific Innovation Officer of Grifols, discusses advancing immunoglobulin (or IG) treatment for immune disorders.
Oncology
Aligning with national efforts to modernise cancer diagnosti...
Andrew Newland, former CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
